About: AS03(B)-Adjuvanted H5N1 Influenza Vaccine in Children 6 Months Through 17 Years of Age: A Phase 2/3 Randomized, Placebo-Controlled, Observer-Blinded Trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: AS03(B)-Adjuvanted H5N1 Influenza Vaccine in Children 6 Months Through 17 Years of Age: A Phase 2/3 Randomized, Placebo-Controlled, Observer-Blinded Trial Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
value	AS03(B)-Adjuvanted H5N1 Influenza Vaccine in Children 6 Months Through 17 Years of Age: A Phase 2/3 Randomized, Placebo-Controlled, Observer-Blinded Trial
subject	Influenza Causal inference Clinical research Bird diseases Design of experiments
part of	AS03(B)-Adjuvanted H5N1 Influenza Vaccine in Children 6 Months Through 17 Years of Age: A Phase 2/3 Randomized, Placebo-Controlled, Observer-Blinded Trial
is hasSource of	covid:ann/target/a27776ac33b65e96f0c7feb70d903ce5d85dbd47 covid:ann/target/c6aa2a8534a9260ffaaf714afc9fd84323489f0f covid:ann/target/615d8656fd812a8cc4b08032c1b97d75ad47733d covid:ann/target/93f57da2a7e144ec9b8e836b5fd72f568c6402c7 covid:ann/target/18b956abb02af5f2aabc45651edeb0353f16999c covid:ann/target/6b8a32440dabc46aca9142a4fbf23532fb6db813 covid:ann/target/996710eb8c33ae545adb98a29c22825a7d9657e1 covid:ann/target/ec17028c0c21225a936e24de313e4b7a78d5e6c3 covid:ann/target/deff9ed6effe23363da89ae67a63f2ee66baaa58 covid:ann/target/72c4c14698e2169a0d205c95db743713e62f8307 covid:ann/target/fdc9b7fc663bf5fc34d26142c9eec60b22e83be6 covid:ann/target/ce3ab6a9b05022a5fcea772799179e9799adce29 covid:ann/target/f612ed1a0fd44f7742358dd68777ca9cb2f6d687 covid:ann/target/081ae01f68b59695b10b815d5d174ae9a372e096 covid:ann/target/1a514b623c559887677d3b68865c92a2b3df64b3 covid:ann/target/b74cd1da14bb7cfeb6d8a3fc2e255b0299023f71 covid:ann/target/c9a62cbd54277f38fc4cfbe005603523f0e051ef covid:ann/target/ecfef294b863a919fb48d18e6681e8698a54b0d0 covid:ann/target/f6b6d31537628a00028148b8c95c6df78a843326 covid:ann/target/f4832d2584de18a0d3c27a8270abe0a502bc3e75 covid:ann/target/110569f98a2a685cc5f11715a6f16439930fc656 covid:ann/target/c00e61aa76cfeb1b19aad26aac0c5022ac01e1cc covid:ann/target/95924d4be6c7e2385f91572c218cc0e2895bb0ec covid:ann/target/9743f123d4a9aee2d3ba163bb253eecf4c2a202a covid:ann/target/c16866f1a784c837c5787696e07ccbf40a152c7e covid:ann/target/03ef75fd8294c93423f05c2e926024eb54f4ade5 covid:ann/target/05250a1a71d0e3b99b289eb704ad7cecd88bd567 covid:ann/target/e4042349ab85cf6e40f4d9b0b53e4d592c8df41a covid:ann/target/49896d6792cd2220370f0f13f127eac63e0fde93
is resource representing a document's title of	AS03(B)-Adjuvanted H5N1 Influenza Vaccine in Children 6 Months Through 17 Years of Age: A Phase 2/3 Randomized, Placebo-Controlled, Observer-Blinded Trial

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software